| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 03/31/2005 | US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response |
| 03/31/2005 | US20050067955 Prepared, for example, by reaction of tetraphenylcyclopentadienone with 1,4-diethynyl-2,5-dimethoxybenzene; can be used as a core material for an organic electroluminescence element or other optical devices |
| 03/31/2005 | US20050067951 For example, N,N'-bis-(4'-(N-triphenylmethyl)-phenyl)-N-naphth-1-yl-amino)-bi-phenylyl)-N,N'-bisphenyl-2,7-amino-9-phenylcarbazole; hole transfer material |
| 03/31/2005 | CA2808646A1 Thalidomide analogs |
| 03/31/2005 | CA2538864A1 Thalidomide analogs as tnf-alpha modulators |
| 03/31/2005 | CA2538454A1 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain |
| 03/31/2005 | CA2538381A1 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3) |
| 03/31/2005 | CA2538291A1 Substituted sulfonamides |
| 03/30/2005 | EP1519239A2 Organophotoreceptor with a charge transport material having at least two azine groups |
| 03/30/2005 | EP1519237A2 Organophotoreceptor with charge transport compound with an azine group |
| 03/30/2005 | EP1518856A1 Process for producing quinolonecarboxylic acid derivative |
| 03/30/2005 | EP1518553A2 Use of nitrate ester compounds for treating pain or providing analgesia |
| 03/30/2005 | EP1517932A2 Heterocyclic nitrogen-containing activators and catalyst systems for olefin polymerization |
| 03/30/2005 | EP1517931A1 Halogen substituted catalyst system for olefin polymerization |
| 03/30/2005 | EP1517930A2 Polymerization catalyst activators, method of preparing and their use in polymerization processes |
| 03/30/2005 | EP1517909A2 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 03/30/2005 | EP1517886A1 Novel phthalamide derivatives |
| 03/30/2005 | EP1438289B1 Indole derivatives as cox ii inhibitors |
| 03/30/2005 | EP1250093B1 Method for preventing fluorescence quenching |
| 03/30/2005 | EP1250092B1 Method for preventing fluorescence quenching |
| 03/30/2005 | CN1602293A Triarylamine derivatives and the use thereof in organic electroluminescent and electrophotographic devices |
| 03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 03/30/2005 | CN1600787A 4, 4'-bis(carbazol-9-yl)-biphenyl based silicone compound and organic electroluminescent device using the same |
| 03/30/2005 | CN1600772A Aryl phenyl substituted cyclic ketoenols |
| 03/30/2005 | CN1194966C Methylation of indole compounds from dimethyl carbonate |
| 03/29/2005 | US6872852 Polyamine analogues as cytotoxic agents |
| 03/29/2005 | US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents |
| 03/29/2005 | US6872835 Process for preparation of fused pyrroles |
| 03/29/2005 | US6872834 Phenyl-substituted indoles and indazoles |
| 03/29/2005 | US6872746 Isomeric fused pyrrolocarbazoles and isoindolones |
| 03/29/2005 | US6872744 Analgesics |
| 03/29/2005 | US6872743 Antiinflammatory agents; sepsis shock; antiarthritic agents |
| 03/29/2005 | US6872737 Drugs such as 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5 -dione inhibitors of glycogen synthase kinase-3 (GSK-3), for prophylaxis of neurodegenerative disorders, cancer, hyperplasia, psoriasis, arteriosclerosis or restinosis |
| 03/29/2005 | US6872699 Truncated Flk-1 receptor protein, methods of use and a recombinant vector containing a nucleotide encoding the truncated Flk-1 protein |
| 03/29/2005 | CA2244190C Method of producing press-moulding materials with polyisocyanate binders and using latent, heat-activable catalysts |
| 03/24/2005 | WO2005026122A1 PROCESS FOR THE PREPARATION OF (1α, 5α, 6α)-6-AMINOMETHYL-3-BENZYL-3-AZBICYCLO[3.1.0]HEXANE |
| 03/24/2005 | WO2005026121A1 PROCESS FOR THE PREPARATION OF (1α, 5α, 6α)-6-AMINOMETHYL-3-BENZYL-3-AZABICYCLO[3.1.0]HEXANE |
| 03/24/2005 | WO2005026120A1 Matrix metalloproteinase inhibitors |
| 03/24/2005 | WO2005026119A1 Method for producing sulfone amide-containing indole compound |
| 03/24/2005 | WO2005026118A1 Crystal of sulfonamide-containing indole compound and process for producing the same |
| 03/24/2005 | WO2005025557A1 An agent for plasminogen-activation and matrix metalloproteinase associated conditions and methods of use |
| 03/24/2005 | WO2005012333A3 Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof |
| 03/24/2005 | WO2005012328A3 Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof |
| 03/24/2005 | WO2005000775A3 Cyclohexyl derivatives as selective estrogen receptor modulators |
| 03/24/2005 | WO2004111193A3 Prodrugs of mitotic kinesin inhibitors |
| 03/24/2005 | WO2004088312A3 Fluorescently tagged ligands |
| 03/24/2005 | WO2004067510A8 3,6-disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 03/24/2005 | WO2004060882A8 Cb 1/cb 2 receptor ligands and their use in the treatment of pain |
| 03/24/2005 | WO2004039795A3 Amide compounds for the treatment of hyperlipidemia |
| 03/24/2005 | US20050065350 Method for forming a carbon-carbon or carbon-heteroatom linkage |
| 03/24/2005 | US20050065305 Superior in hole injecting property, making it unnecessary to add a strongly acidic dopant for enhancing hole injecting property; may be useful in flat panel display devices |
| 03/24/2005 | US20050065217 Trimethoxyphenyl indole ligandl cytiotoxic: anticancer agents |
| 03/24/2005 | US20050065211 Ester derivatives |
| 03/24/2005 | US20050065193 Carbamates of 2-heterocyclic-1,2-ethanediols |
| 03/24/2005 | US20050065191 Central nervous system disorders; therapy for diseases of glutamate receptor signal transmission |
| 03/24/2005 | US20050065162 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 03/24/2005 | US20050065142 Antidiabetic agents; therapy for insulin resistance |
| 03/24/2005 | US20050065095 Antibacterial agents |
| 03/24/2005 | US20050065093 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/24/2005 | US20050064335 Indolestyryl compound for use in recording media and method for fabrication thereof |
| 03/24/2005 | US20050064238 Excellent blue light emission characteristics and hole transfer capability; organic electroluminescent device (OLED) with high efficiency, a high luminance, a long life span, and a low power consumption; dinaphthylbis(3,5-(dicarbazol-9-yl)phenyl)silane for example |
| 03/24/2005 | CA2538315A1 Matrix metalloproteinase inhibitors |
| 03/24/2005 | CA2536995A1 Crystalline sulfonamide-containing indole compound and process for preparing the same |
| 03/23/2005 | EP1516877A1 Amine derivatives as protease inhibitors |
| 03/23/2005 | EP1516871A1 Benzoindoline derivatives with adrenergic activity |
| 03/23/2005 | EP1515941A1 2-naphthamide derivatives |
| 03/23/2005 | EP1515730A1 Novel maxi-k channel blockers, methods of use and process for making the same |
| 03/23/2005 | EP1515721A1 Ophthalmic compositions for treating ocular hypertension |
| 03/23/2005 | EP1515717A1 Calcium salts of indole derived statins |
| 03/23/2005 | EP1515716A2 Indole derivatives having anti-angiogenetic activity |
| 03/23/2005 | EP1152764A4 Compositions and methods for use in targeting vascular destruction |
| 03/23/2005 | EP1147074B1 Synthesis method of nitroxymethylphenyl esters of aspirin derivatives |
| 03/23/2005 | CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 03/23/2005 | CN1599725A Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control |
| 03/23/2005 | CN1599720A Tetrahydrocarbazol derivatives as ligands for g-protein-coupled receptors (gpcr) |
| 03/23/2005 | CN1599719A Crystals of non-natural-type stereoisomer salt of monatin and use thereof |
| 03/23/2005 | CN1599718A Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
| 03/23/2005 | CN1599717A Cyclic diamine compounds having fused-ring groups |
| 03/23/2005 | CN1598698A Organophotoreceptor with charge transport compound with an azine group |
| 03/23/2005 | CN1597672A Substituierte benzoylcyclohexandione |
| 03/23/2005 | CN1597667A Quinazoline derivatives as angiogenesis inhibitors |
| 03/23/2005 | CN1597111A Catalyst for preparation indole using o-ethyl aniline catalytic dehydrocyclization and its preparation method |
| 03/23/2005 | CN1194000C Metallophenyl cyclopentadienyl phthalocyanine derivative, its preparation method and application |
| 03/23/2005 | CN1193996C Inhibitor used as antioxygen and 5-lipoxygenase, and anti-inflammatory non-steroid carboxylic ester and amide of non-steroid anti-inflammatory agent |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/22/2005 | US6869974 Pharmaceutical compounds |
| 03/22/2005 | US6869957 Non-peptide tachykinin receptor antagonists |
| 03/22/2005 | US6869953 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents |
| 03/22/2005 | US6869904 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom |
| 03/22/2005 | CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same |
| 03/17/2005 | WO2005023903A1 Novel approach to reduce cyclics formation in the production of polyetherimides |
| 03/17/2005 | WO2005023818A2 Heterobicyclic compounds as pharmaceutically active agents |
| 03/17/2005 | WO2005023255A2 Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process |
| 03/17/2005 | WO2005023246A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp) |
| 03/17/2005 | WO2005023245A1 Novel cycloalkyl’b! condensed indoles |
| 03/17/2005 | WO2005023196A2 Compounds and methods |
| 03/17/2005 | WO2005005415A8 Indoles useful in the treatment of inflammation |
| 03/17/2005 | WO2003043619A8 New use for the treatment of gastroesophageal reflux disease |
| 03/17/2005 | WO2002050028A8 Substituted benzoindoles as spla2 inhibitors |
| 03/17/2005 | US20050059826 Agonists, antagonists or inverse agonists for brain receptors; anxiolytics, antidepressants; nervous system, sleep and psychological disorders; Down syndrome, cognition activators |